Related Experiment Video
Updated: Jul 28, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Cost of childhood cancer treatment in Ethiopia
Mizan Kiros Mirutse1,2, Michael Tekle Palm3, Mieraf Taddesse Tolla1
1Department of Global Public Health and Primary Care, Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen, Bergen, Norway.
Insights
The annual cost to run Ethiopia's pediatric oncology unit was USD 776,060, or USD 577 per child. Childhood cancer treatment in Ethiopia appears affordable, warranting further cost-effectiveness studies.
Area of Science:
- Health Economics
- Pediatric Oncology
- Public Health Policy
Background:
- Ethiopia's National Childhood and Adolescent Cancer Control Plan (NCACCP) highlights the need to expand pediatric oncology services.
- There is limited data on the operational costs of pediatric oncology units and childhood cancer treatment in Ethiopia.
Purpose of the Study:
- To estimate the total annual cost of operating a pediatric oncology unit.
- To determine the cost per treated child and per specific service (e.g., outpatient visit, bed day).
Main Methods:
- A mixed (top-down and bottom-up) costing approach was used from a provider perspective.
- Historical cost data and service quantities were collected for a pediatric oncology unit and other hospital departments over one year.
- Direct costs (personnel, drugs, supplies, equipment) and overheads were aggregated to calculate total and unit costs.
Main Results:
- The total annual cost for the pediatric oncology unit was USD 776,060 (USD 577 per child).
- Cost per treated child varied from USD 469 to USD 1,085 based on sensitivity analysis.
- Drugs/supplies (33%) and human resources (27%) were major cost drivers; inpatient care constituted 63% of costs.
Conclusions:
- Operating a pediatric oncology unit in Ethiopia is likely affordable.
- Further research on cost-effectiveness, equity, and financial protection is recommended to guide childhood cancer control interventions.
Background:
Despite the recent interest in expanding pediatric oncology units in Ethiopia, reflected in the National Childhood and Adolescent Cancer Control Plan (NCACCP), little is known about the cost of running a pediatric oncology unit and treating childhood cancers.
Methods:
We collected historical cost data and quantity of services provided for the pediatric oncology unit and all other departments in Tikur Anbessa Specialized Hospital (TASH) from 8 July 2018 to 7 July 2019, using a provider perspective and mixed (top-down and bottom-up) costing approaches. Direct costs (human resources, drugs, supplies, medical equipment) of the pediatric oncology unit, costs at other relevant clinical departments, and overhead cost share are summed up to estimate the total annual cost of running the unit. Further, unit costs were estimated at specific childhood cancer levels.
Results:
The estimated annual total cost of running a pediatric oncology unit was USD 776,060 (equivalent to USD 577 per treated child). The cost of running a pediatric oncology unit per treated child ranged from USD 469 to USD 1,085, on the scenario-based sensitivity analysis. Drugs and supplies, and human resources accounted for 33% and 27% of the total cost, respectively. Outpatient department and inpatient department shared 37% and 63% of the cost, respectively. For the pediatric oncology unit, the cost per OPD visit, cost per bed day, and cost per episode of hospital admission were USD 36.9, 39.9, and 373.3, respectively. The annual cost per treated child ranged from USD 322 to USD 1,313 for the specific childhood cancers.
Conclusion:
Running a pediatric oncology unit in Ethiopia is likely to be affordable. Further analysis of cost effectiveness, equity, and financial risk protection impacts of investing in childhood cancer programs could better inform the prioritization of childhood cancer control interventions in the Ethiopia Essential Health Service Package.
Related Concept Videos
Treatment Resistant Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...

